Holen Sie sich die Stockscreener-App
11.18
1.37%
0.1228
Schlusskurs vom Vortag:
$11.05
Offen:
$11.3
24-Stunden-Volumen:
743.21K
Relative Volume:
0.23
Marktkapitalisierung:
$1.50B
Einnahmen:
$24.30M
Nettoeinkommen (Verlust:
$-145.57M
KGV:
-8.4044
EPS:
-1.33
Netto-Cashflow:
$-149.17M
1W Leistung:
+25.49%
1M Leistung:
+22.88%
6M Leistung:
+85.54%
1J Leistung:
+246.95%
1-Tages-Spanne:
$10.93
$11.34
1-Wochen-Bereich:
$8.66
$12.11
52-Wochen-Spanne:
$1.03
$12.11
Tango Therapeutics Inc Stock (TNGX) Company Profile
Firmenname
Tango Therapeutics Inc
Sektor
Branche
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie TNGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
11.15 | 1.49B | 24.30M | -145.57M | -149.17M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.67 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.37 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
813.75 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.69 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | Wolfe Research | Peer Perform |
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-08 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-20 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor - Sahm
Can Tango Therapeutics Inc. stock sustain market leadershipJuly 2025 Macro Moves & Weekly Return Optimization Plans - ulpravda.ru
How Tango Therapeutics Inc. stock reacts to oil prices2025 Institutional Moves & Stock Timing and Entry Methods - ulpravda.ru
Can Tango Therapeutics Inc. stock resist market sell offsJuly 2025 Macro Moves & Safe Capital Growth Plans - ulpravda.ru
Will Tango Therapeutics Inc. stock deliver long term returnsTrade Exit Summary & Daily Price Action Insights - ulpravda.ru
Tango Therapeutics' CEO Retires, Successor Appointed; Shares Fall - MarketScreener
Is Tango Therapeutics Inc. stock a defensive play in 2025Dip Buying & Short-Term High Return Ideas - ulpravda.ru
Tango Therapeutics announces CEO transition: Barbara Weber to retire, Malte Peters appointed successor - MarketScreener
Tango Therapeutics appoints new CEO amid leadership transition - TipRanks
Tango Therapeutics appoints Malte Peters as new CEO By Investing.com - Investing.com India
Tango Therapeutics appoints Malte Peters as new CEO - Investing.com
Cancer drug developer Tango brings in new leader as trials advance - Stock Titan
Tango Therapeutics stock hits 52-week high at $11.21 By Investing.com - Investing.com Nigeria
Tango Therapeutics stock hits 52-week high at $11.21 - Investing.com India
Tango Therapeutics appoints Sung Lee to board of directors By Investing.com - Investing.com Nigeria
Tango Therapeutics Adds Independent Director to Strengthen Governance - TipRanks
Tango Therapeutics appoints Sung Lee to board of directors - Investing.com
Tango Therapeutics adds independent director to strengthen governance - MSN
Tango Therapeutics Appoints Sung Lee to Board of Directors - Yahoo Finance
Hindware Home Innovation Limited Reaches Critical Trendline SupportStraddle and Strangle Trades & Low Risk Investment Plans - earlytimes.in
Tango Therapeutics (NASDAQ:TNGX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Tango Therapeutics (NASDAQ:TNGX) Nasdaq index Notes Liquidity Move - Kalkine Media
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors - MSN
Patterns Watch: How Tango Therapeutics Inc stock reacts to oil pricesDip Buying & Safe Entry Point Identification - moha.gov.vn
Tango Therapeutics (TNGX) Upgraded to Buy: Here's Why - MSN
3 Stocks With Strong Upside Potential for 2026 Gains - Tokenist
Biotech Stocks: Jefferies Names its 6 Top Picks for 2026 - Investing.com
Certain Common Stock of Tango Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2025. - marketscreener.com
Certain Restricted Stock Units of Tango Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2025. - marketscreener.com
Certain Pre-Funded Warrants of Tango Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2025. - marketscreener.com
3 Biotech Stocks Wall Street Analysts Are Bullish on for 2026 - WV News
Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Tango Therapeutics Inc. stock a smart buy before Fed meetingJuly 2025 Sentiment & Fast Entry High Yield Tips - Улправда
Will Tango Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Trends & AI Driven Stock Reports - Улправда
Why Tango Therapeutics Inc. stock remains a top recommendationMarket Trend Report & Technical Pattern Based Signals - DonanımHaber
Will Tango Therapeutics Inc. stock deliver strong dividend growthProduct Launch & Real-Time Volume Analysis - DonanımHaber
Can Tango Therapeutics Inc. stock reach $100 price target2025 Sector Review & High Accuracy Swing Entry Alerts - Улправда
5 Biotech Stocks to Watch for Potential Upside - The Globe and Mail
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Tango Therapeutics (NASDAQ:TNGX) Stock Price Up 7.6%Here's What Happened - MarketBeat
Is Tango Therapeutics (TNGX) Overvalued After a 200% One-Year Surge? A Fresh Look at Its Pricing - Yahoo Finance
Highs Report: Is Tango Therapeutics Inc stock a defensive play in 2025Portfolio Performance Report & Risk Managed Investment Signals - moha.gov.vn
Tango Therapeutics (NASDAQ:TNGX) Raised to Buy at Wall Street Zen - MarketBeat
Stempoint Capital LP Acquires Shares of 208,800 Tango Therapeutics, Inc. $TNGX - MarketBeat
Can Tango Therapeutics (TNGX) climb 37.28% to reach the level Wall Street analysts expect? - MSN
Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 4.6%Should You Sell? - MarketBeat
Vivo Capital LLC Purchases Shares of 600,000 Tango Therapeutics, Inc. $TNGX - MarketBeat
Tango Therapeutics, Inc. $TNGX Stock Holdings Trimmed by XTX Topco Ltd - MarketBeat
Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect? - Finviz
Tango Therapeutics CFO Beckman sells $25,281 in stock - MSN
Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 32% - simplywall.st
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):